Z. Rosenberg: Overview on the use of microbicides, their role in HIV prevention
Zeda Rosenberg, Sc.D. is the founding Chief Executive Officer of the International Partnership for Microbicides, a non-profit product development partnership established to prevent HIV transmission by accelerating the development and availability of a safe and effective microbicide for use by women in developing countries. In addition to raising financial support for its product development efforts, IPM has focused on expanding access to promising products by acquiring royalty-free licenses from several major
Zeda Rosenberg, Sc.D. is the founding Chief Executive Officer of the International Partnership for Microbicides, a non-profit product development partnership established to prevent HIV transmission by accelerating the development and availability of a safe and effective microbicide for use by women in developing countries. In addition to raising financial support for its product development efforts, IPM has focused on expanding access to promising products by acquiring royalty-free licenses from several major pharmaceutical companies for drugs to develop as microbicides.
Previously, Dr. Rosenberg was the Scientific Director for the HIV Prevention Trials Network (HPTN) at Family Health International from 1999 to 2002. From 1987-1999, Dr. Rosenberg worked at the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. NIH. In her role as Senior Scientist at the Division of AIDS, she was responsible for HIV prevention clinical trials in adult populations. As Assistant Director for Prevention Research, she coordinated prevention activities in the areas of HIV infection and other sexually transmitted diseases as well as tuberculosis.
Dr. Rosenberg received her undergraduate degree (A.B.) in biology and mathematics from Douglass College, Rutgers University; a master’s degree (S.M.) in epidemiology and a doctoral degree (Sc.D.) in microbiology from the Harvard School of Public Health.